6748.TWO
Price:
$68.5
Market Cap:
$4.19B
ACRO Biomedical Co., Ltd. develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine. The company was founded on June 26, 2014 and is headquartered in Kaoshiung, Taiwan.
Industry
Medical - Specialties
IPO Date
2021-07-27
Stock Exchange
TWO
Ticker
6748.TWO
According to ACRO Biomedical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -53.10. This represents a change of 163.05% compared to the average of -20.19 of the last 4 quarters.
The mean historical PE Ratio of ACRO Biomedical Co., Ltd. over the last ten years is -22.10. The current -53.10 PE Ratio has changed 23.93% with respect to the historical average. Over the past ten years (40 quarters), 6748.TWO's PE Ratio was at its highest in in the December 2022 quarter at -7.48. The PE Ratio was at its lowest in in the December 2023 quarter at -57.19.
Average
-22.10
Median
-21.07
Minimum
-49.68
Maximum
0
Discovering the peaks and valleys of ACRO Biomedical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 219.23%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -49.68
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -25.19 | -49.30% |
| 2023 | -49.68 | 219.23% |
| 2022 | -15.56 | -16.01% |
| 2021 | -18.53 | -21.50% |
| 2020 | -23.61 | -Infinity% |
The current PE Ratio of ACRO Biomedical Co., Ltd. (6748.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-30.15
5-year avg
-26.52
10-year avg
-22.10
ACRO Biomedical Co., Ltd.’s PE Ratio is greater than Medigen Biotechnology Corp. (-68.66), less than Bionime Corporation (-34.77), greater than UnicoCell Biomed Co., Ltd. (-54.00), less than Nang Kuang Pharmaceutical Co., Ltd. (14.49), less than BRIM Biotechnology, Inc. (-15.95), less than Energenesis Biomedical CO.,LTD. (-13.33), less than Maxigen Biotech Inc. (18.87), less than Orient EuroPharma Co., Ltd. (-11.98), less than Synbio Tech Inc. (17.03), less than Senhwa Biosciences, Inc. (-12.86),
| Company | PE Ratio | Market cap |
|---|---|---|
| -68.66 | $4.28B | |
| -34.77 | $3.93B | |
| -54.00 | $4.81B | |
| 14.49 | $3.86B | |
| -15.95 | $3.70B | |
| -13.33 | $3.81B | |
| 18.87 | $3.94B | |
| -11.98 | $3.89B | |
| 17.03 | $3.25B | |
| -12.86 | $3.59B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ACRO Biomedical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ACRO Biomedical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ACRO Biomedical Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for ACRO Biomedical Co., Ltd. (6748.TWO)?
What is the highest PE Ratio for ACRO Biomedical Co., Ltd. (6748.TWO)?
What is the 3-year average PE Ratio for ACRO Biomedical Co., Ltd. (6748.TWO)?
What is the 5-year average PE Ratio for ACRO Biomedical Co., Ltd. (6748.TWO)?
How does the current PE Ratio for ACRO Biomedical Co., Ltd. (6748.TWO) compare to its historical average?